RXD News and Press, ProShares UltraShort Health Care From 02/06/20

By Michelle Borré, CFA, Head of Fundamental Alternative Strategies , and Brian Giesen, CFA, Intermediate Research Analyst Restrictions on the pricing of drugs delivered in doctors' offices and hospitals could have significant investment implications. The Trump Administration is...

The presidential election year has begun, and the rhetoric around healthcare policy is likely to get louder as campaigning heats up. Tony DeSpirito talks with Portfolio Manager Erin Xie about the implications for health care stocks. In a year-end poll of our Fundamental Active Equity inves...

By Stephen H. Dover, CFA, Executive Vice President, Head of Equities, Krzysztof Musialik, CFA, Research Analyst, Franklin Templeton Emerging Markets Equity, and Steve Kornfeld, CFA, Portfolio Manager, Research Analyst, Franklin Equity Group The biopharma industry has the potential to save...

By Andy Acker, CFA & Luyi Guo, Ph.D., CFA & Rich Carney, CFA Last week, the Trump administration abandoned plans to overhaul drug rebates in Medicare while a federal judge ruled against listing prescription drug prices in TV ads. But U.S. drug reform is far from over, with implica...

By Stephen H. Dover, Executive Vice President, Head of Equities; Aman Gupta, Portfolio Manager, Research Analyst, Franklin Mutual Series; Brian DeChristopher, Research Analyst, Franklin Equity Group; Evan McCulloch, Portfolio Manager, Director of Equity Research, Franklin Equity Group; Krzysz...

President Trump will issue an executive order on Monday related to healthcare price transparency, according to WSJ sources . More news on: Health Care Select Sect SPDR ETF, Vanguard Health Care ETF, iShares U.S. Healthcare ETF, Healthcare stocks news, News on ETFs Read more ...

By Tony DeSpirito Markets tend to focus on one risk at a time, and it’s fragile U.S.-China relations that are front and center now. New blog contributor Tony DeSpirito offers up two potential takeaways for equity investors. Headlines over the U.S.-China trade dispute have been p...

By Marshall Gordon and Nicholas Wu, PhD Healthcare stocks normally react to political rhetoric, but the speed and magnitude of the recent correction in the sector have been surprising. Despite bipartisan clamoring for broad changes to the healthcare system and the Trump administration'...

By Andy Acker, CFA & Rich Carney, CFA A proposal to expand Medicare and eliminate private insurance in the U.S. pummeled healthcare stocks recently. Portfolio Manager Andy Acker and Research Analyst Rich Carney explain what it means for investors. It's been a tough few weeks for he...

The Dow reached a 7-month high last Thursday and Nasdaq topped 8,000 on Wednesday as both indexes (and the S&P 500) are only a little over 1% below their all-time highs, set last fall. The biggest news last week was that the Apple ([[AAPL]]) and Qualcomm ([[QCOM]]) settlement on Tues...